MolecuLight® improves success with
Burn Wounds

Compared to standard examination, MolecuLight fluorescence imaging offered a superior method for detecting bacterial burden in burn wounds, allowing for targeted swabbing of bacterial-laden regions within large wounds.

MolecuLight imaging reliably predicted burn wound infections following split-thickness​ skin grafting, with positive and negative predictive values of 82% and 90%.

First study to show that fluorescence imaging can visualize clinically significant bacterial burden in pediatric burn wounds and is easily incorporated into routine pediatric burn wound assessment.

MolecuLight significantly improved the accuracy of identifying wound infections in pediatric burn patients compared to visual assessment alone, in turn better informing wound management at the point-of-care.

This review summarizes evidence demonstrating the benefits of fluorescence imaging for burn wound assessment, with a focus on improved bacterial detection.

MolecuLight® shows remarkable accuracy in assessing recipient sites and predicting skin graft take/loss outcomes among burn patients.

CMS requires documentation that wounds are free of infection before skin substitute/graft application. MolecuLight® is the only tool that provides graphical evidence of adequate wound bed preparation.